Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Long-Term Debt Repayments (2016 - 2025)

Haemonetics has reported Long-Term Debt Repayments over the past 16 years, most recently at $4.7 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments fell 90.32% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $4.7 million, down 91.24%, while the annual FY2025 figure was $50.0 million, 308.16% up from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $4.7 million at Haemonetics, up from -$1.6 million in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $50.0 million in Q2 2024 and troughed at -$48.4 million in Q3 2024.
  • A 5-year average of $7.0 million and a median of $3.5 million in 2023 define the central range for Long-Term Debt Repayments.
  • On a YoY basis, Long-Term Debt Repayments climbed as much as 2757.14% in 2024 and fell as far as 1483.91% in 2024.
  • Year by year, Long-Term Debt Repayments stood at $4.4 million in 2021, then tumbled by 60.0% to $1.8 million in 2022, then surged by 100.0% to $3.5 million in 2023, then soared by 1283.91% to $48.4 million in 2024, then plummeted by 90.32% to $4.7 million in 2025.
  • Business Quant data shows Long-Term Debt Repayments for HAE at $4.7 million in Q4 2025, -$1.6 million in Q3 2025, and $1.6 million in Q2 2025.